Research Archive — Page 33 of 131
-
November 15, 2023
Study finds many patients don’t seek more health services after receiving genetic screening results
A study by Vanderbilt researchers found that more than half of the patients who receive the results of genetic tests might not be impelled to seek more services than they're already receiving. -
November 15, 2023
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. -
November 15, 2023
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. -
November 13, 2023
Study finds antiviral treatment is largely underused in children with influenza
Vanderbilt research finds antiviral medications are underused in young children diagnosed with influenza despite national guidelines supporting their use -
November 13, 2023
Most can lower blood pressure by reducing salt, even those on BP drugs: study
New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake. -
November 10, 2023
After 40 years, genetics still surprises VUMC’s Nancy Cox
As she looks back on her 40-plus year career, what surprises Nancy Cox, PhD, an internationally known geneticist at Vanderbilt University Medical Center, is how much progress has been made, and yet how much more there is to learn about the role genetic variation plays in human disease. -
November 6, 2023
Children’s antibodies highly potent against COVID-19: study
Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants.